Leaflet TROXEVASIN 2% gel
Indicated for: chronic venous insufficiency; capillary fragility
Route of administration: cutaneous
Substance: troxerutine (vasodilator)
ATC: C05CA04 (Cardiovascular system | Capillary stabilizing agents | Bioflavonoids)
This medicine may cause dizziness or vertigo.
May lower blood pressure and increase the risk of falls.
Troxerutin is a semisynthetic flavonoid used in the treatment of chronic venous disorders such as chronic venous insufficiency, varicose veins, and hemorrhoids. This compound has antioxidant, anti-inflammatory, and vasoprotective properties, helping to reduce inflammation and improve venous tone.
Troxerutin is available in the form of capsules, tablets, or topical gels. Oral administration is used to treat systemic symptoms such as pain, swelling, and a feeling of heaviness in the legs, while gels are applied locally to relieve skin-level symptoms.
Side effects are rare but may include allergic reactions, nausea, or gastric discomfort. It is important to use troxerutin as directed by a physician, especially in patients with pre-existing conditions.
Troxerutin is an effective therapeutic option for managing chronic venous disorders, helping to reduce symptoms and improve patients' quality of life.
General data about TROXEVASIN 2%
- Substance: troxerutine
- Date of latest medicines list: 01-07-2013
- Product code: W10088001
- Concentration: 2%
- Pharmaceutical form: gel
- Quantity: 1
- Product type: Generic medicine
- Prescription status: OTC - Over the Counter = medicine that does not require a medical prescription.
Pharmaceutical forms available for troxerutine
Concentrations available for troxerutine
- 1000mg
- 2%
- 20mg/g
- 300mg
- 3500mg